S&P 500 · Health Care · USD · FY end 2025-12-31
Quest Diagnostics (DGX) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 11.04B | 992.00M | 8.75 | 1.36B |
| FY2024 | 9.87B | 871.00M | 7.69 | 909.00M |
| FY2023 | 9.25B | 854.00M | 7.49 | 864.00M |
| FY2022 | 9.88B | 946.00M | 7.97 | 1.31B |
| FY2021 | 10.79B | 2.00B | 15.55 | 1.83B |